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Abstract
Several cationic lipids which are highly efficient for delivering genes in vitro do not increase gene delivery in vivo after an
intramuscular injection. In order to elucidate the origin of this phenomenon, we have studied the cellular uptake and
intracellular fate of cationic lipid/DNA complexes in vitro on myogenic mouse cells (myoblasts and myotubes) of the C2 cell
line and of primary cultures. We used a cationic lipid with a spermine head group and its fluorescent analog, and a
fluorescent plasmid obtained by nick-translation. In myoblasts, transgene expression was obtained and lipoplexes were
internalized in cytoplasmic vesicles. In myotubes, no transgene expression could be detected and we observed an absence of
lipoplex internalization. The in vitro uptake of cationic lipid was inversely correlated with the degree of fusion of C2 cell
myotubes cultures. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Injection of ‘naked’ plasmid DNA into skeletal
muscle results in e⁄cient transgene expression in my-
o¢bers [1^4]. This is in contrast to what is observed
in many other tissues, where naked DNA is poorly
e⁄cient. Skeletal muscle may thus be one type of
tissue able to take up and express naked plasmid
DNA. This suggests that a unique cytoarchitectural
feature of striated muscle is responsible for this phe-
nomenon. T-tubules and caveolae might play a role
in the uptake of plasmid DNA [5]. Triadin, a protein
located in the sarcoplasmic reticulum, might also be
involved in this internalization mechanism [6,7].
Several non-viral vectors are used for increasing
transgene expression. Among them, cationic lipids
have the following advantages: they protect and de-
liver DNA e⁄ciently, both in vitro and in vivo after
intravenous, intracerebral, or intratumoral injection
[8]. They are non-immunogenic and are easy to pro-
duce in large quantities. Formulation of polyanionic
DNA with cationic lipids results in condensed par-
ticles, referred to as lipoplexes [9,10]. It seems clear
that cationic lipids induce the cellular uptake of the
lipoplexes by condensing the DNA and generating a
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horse serum; Luc, luciferase; PBS, phosphate-bu¡ered saline,
pH 7.4; X-gal, 5-bromochloro-3-indolyl-L-D-galactopyranoside
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particle with speci¢c size and positive charge surface.
Because of the net negative charge exhibited by the
plasma membrane, lipoplexes probably bind to the
cell membrane through ionic interactions. The route
and mechanism whereby exogenous DNA enters the
cell and reaches the nuclear compartment following
internalization remain poorly understood. Most au-
thors suggest that intracellular delivery of DNA oc-
curs via endocytosis [11^13], whereas others propose
that fusion events at the plasma membrane are in-
volved in the uptake of DNA [14,15]. Phagocytosis
and pinocytosis have also been proposed to account
for the internalization process of lipoplexes [16].
Surprisingly, several cationic lipids were found un-
able to increase gene transfer in skeletal muscle in
vivo ([5]; B. Pitard et al., unpublished data). How-
ever, gene transfer into myogenic cells in culture
needs the use of a vector such as a cationic lipid
[5,17].
In the present work, we have studied the cellular
uptake and intracellular fate of DNA/cationic lipids
complexes in vitro on C2 myogenic cells (myoblasts
and myotubes) and on primary muscular culture,
using a £uorescent cationic lipid with a spermine
head group and a £uorescent plasmid. The in vitro
uptake of cationic lipid was inversely correlated with
the degree of fusion of C2 cell myotubes cultures.
2. Materials and methods
2.1. Cell culture
C2C12 and C2C7 are subclones of the C2 cell line
isolated from adult mice skeletal muscle [18]. Myo-
blasts were grown in Dulbecco’s modi¢ed Eagle’s
medium (DMEM, Gibco, Grand Island, NY) supple-
mented with 10% (v/v) fetal bovine serum (FBS, Gib-
co), glutamine (2 mM, Gibco) and penicillin/strepto-
mycin (100 U/ml and 100 Wg/ml, respectively, Gibco).
Cultures were maintained at 37‡C in a 5% CO2/air
incubator. For myotubes cultures, the medium over-
lying con£uent myoblasts cultures was replaced with
DMEM containing 0.5% (v/v) FBS, glutamine
(2 mM) and penicillin/streptomycin (100 U/ml and
100 Wg/ml, respectively), to induce fusion.
Primary myoblasts cultures were obtained by dis-
sociation with collagenase type I (2 mg/ml, Gibco)
and trypsin (0.125%, Gibco) of limb muscle from
neonatal normal OF1 mice. Myoblasts were seeded
onto 35-mm-diameter gelatin-coated dishes as de-
scribed [19]. Myoblasts cultures were grown in
DMEM supplemented with 10% (v/v) horse serum
(HS, Gibco), 10% (v/v) FBS, 1.25% (v/v) chick em-
bryo extract (Gibco), glutamine (2 mM) and penicil-
lin/streptomycin (100 U/ml and 100 Wg/ml, respec-
tively). Four days later, medium was changed to
di¡erentiation medium, i.e. DMEM supplemented
with 10% HS, 2 mM glutamine and penicillin/strep-
tomycin.
2.2. Plasmids
pCMV-Luc plasmid (pXL 2621) (D. Debono,
Rho“ne-Poulenc Rorer) carries a cassette containing
the enhancer^promoter from the immediate early
gene of cytomegalovirus (CMV), the gene coding
for the luciferase and the polyadenylation site of
SV40.
pCMV-nls-LacZ plasmid (pXL 2997) (S. Somarri-
ba, Rho“ne-Poulenc Rorer) carries a cassette contain-
ing the enhancer^promoter from the immediate early
gene of cytomegalovirus (CMV), the gene coding for
the L-galactosidase with a nuclear localization signal
and the polyadenylation site of SV40.
Plasmids were grown using standard techniques
and were puri¢ed using Wizard Megaprep kit (Prom-
ega, Madison, WI). Fluorescent plasmid was pre-
pared by nick translation with dUTP-Red (Amer-
sham, Les Ulis, France) as described previously
[20]. These conditions were optimized to obtain
only labeled full-length plasmid DNA, which was
checked by gel electrophoresis.
2.3. Cationic lipids preparation and lipofection
Myoblasts from C2 cell lines were seeded 3 days
before the experiment into 12-well culture plates
(10 000 cells per well). Myotubes from C2 cell lines
were obtained from myoblasts culture seeded into
12-well culture plates coated with gelatin (150 000
cells per well) and grown 3 days in 10% FBS, then
3^4 days in di¡erentiation medium.
The lipopolyamine used in this study, RPR 120535
was synthesized and characterized as described pre-
viously [21]. Cationic lipid was diluted in 150 mM
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NaCl. Plasmid pXL 2621 was diluted in 150 mM
NaCl, and mixed with an equal volume of cationic
lipid solution. The ¢nal DNA/cationic lipid mixture
was vortexed, left for 10 min at room temperature,
diluted in culture medium in the absence of FBS and
then added to the cells that had been previously
washed twice with fresh medium without FBS. The
lipofection was performed in the following condi-
tions: 1 Wg of DNA and 3 nmol of RPR 120535
per culture well. After 2 h at 37‡C, 10% (v/v) of
FBS or 0.5% (v/v) of FBS was added to the culture
wells for C2 myoblasts and C2 myotubes, respec-
tively. The cells were then incubated for 24 h at
37‡C in the presence of 5% CO2. The transfected
cells were washed twice with PBS and lysed with
200 Wl of cell culture lysis reagent (25 mM Tris-phos-
phate, pH 7.8, 2 mM DTT, 2 mM 1,2-diaminocyclo-
hexane-N,N,NP,NP-tetraacetic acid, 10% glycerol, 1%
Triton X-100, Promega, Madison, WI, USA). Lucif-
erase expression was quanti¢ed on 5 Wl of centri-
fuged lysate supernatant, using a luciferase assay
kit (Promega). Light emission was measured by in-
tegration over 10 s at 25‡C using a Lumat LB9501
luminometer (EGpG, Berthold, Evry, France). Rel-
ative light units (RLU) were calculated versus back-
ground activity. Light emission was normalized to
the protein concentration of each sample, determined
using the Pierce BCA assay (Pierce, Rockford, IL,
USA).
2.4. Cationic lipid quanti¢cation
RPR 121653 is a derivative of RPR 120535, which
bears a covalently linked rhodamine moiety [20].
Cells were transfected with 1 Wg of DNA, 3 nmol
of RPR 120535 and 1 nmol of RPR 121653 per cul-
ture well, as described above. The transfected cells
were washed twice with PBS, and lysed with 200 Wl
of cell culture lysis reagent (Promega). The lysate was
centrifuged at 12 000Ug for 5 min, and a 100-Wl ali-
quot of the supernatant was used to measure the
£uorescence (excitation 544 nm, emission at 590 nm)
in a Titertek Fluoroskan II. The amount of cationic
lipid RPR 121653 contained in the lysate was deter-
mined by comparison with the £uorescent signal ob-
tained with serial dilutions of known amounts of the
cationic lipid in the same bu¡er, and was normalized
to the protein concentration of each sample. Statis-
tical analysis was performed with Student’s t-test.
2.5. Plasmid quanti¢cation
The cells were transfected with £uorescent labeled
plasmid (1 Wg per well) and 3 nmol of RPR 120535,
as described above. At the end of the transfection,
the cells were washed twice with PBS and trypsi-
nized. The cellular suspensions from eight 4-cm2 cul-
ture wells were pooled and centrifuged at 14 000Ug
for 4 min at room temperature. The cell pellet was
lysed with 200 Wl of cell culture lysis reagent (Prom-
ega). The lysate was centrifuged at 12 000Ug for
5 min, and a 100-Wl aliquot of the supernatant was
used to measure £uorescence (excitation 544 nm,
emission at 590 nm) in a Titertek Fluoroskan II.
The amount of £uorescent labeled plasmid con-
tained in the lysate was determined by comparison
with the £uorescent signal obtained with serial dilu-
tions of known amounts of dUTP-Red, and was nor-
malized to the protein concentration of each sample.
Statistical analysis was performed with Student’s
t-test.
2.6. Uptake studies
Myoblasts and myotubes from C2 cell lines were
seeded as described above. Primary myotubes were
obtained after 7 days in di¡erentiation medium.
Cells were transfected with £uorescent cationic lip-
id and £uorescent DNA, in the following conditions:
1 Wg of DNA, 3 nmol of RPR 120535 and 0.1 nmol
of RPR 121653, or incubated with FluoroSpheres
(100- or 200-nm-diameter carboxylate-modi¢ed mi-
crospheres, red £uorescent, at a ¢nal concentration
of 3.109 particles/ml, Molecular Probes, Interchim,
Montluc,on, France). After 24 h at 37‡C, cells were
rinsed three times with PBS, then ¢xed for 10 min in
methanol at room temperature and washed with
PBS. Nuclei were stained with DAPI (500 ng/ml)
for 20 min and the cells were mounted in Mowiol
for examination.
Cells were incubated with 1 mg/ml of rhodamine
B-dextran conjugates (70 000 MW, Molecular
Probes) in DMEM, for 2 h at 37‡C, then incubated
for 1 h in DMEM, ¢xed for 10 min in methanol at
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room temperature, stained with DAPI and mounted
for observation.
Slides were observed with a Zeiss Axiophot micro-
scope equipped with phase-contrast and epi£uores-
cence optics (Zeiss, Le Pecq, France). Images were
captured with a cooled CCD camera (Hamamatsu)
and analyzed with Samba imaging software (Unilog,
Meylan, France).
Fig. 1. (A) Expression of nls-L-galactosidase in a myotube from primary culture after nuclear microinjection. One nucleus was injected
with pCMV-nls-LacZ plasmid at 0.5 Wg/Wl and incubated for 4 h at 37‡C. nls-L-galactosidase was revealed with X-gal staining (see
Section 2). Note the presence of a di¡use staining around nuclei expressing nls-L-galactosidase (marked with a star). Arrows indicate
the nuclei of the same myotube where no expression of the transgene was detected. (B) Phase contrast of C2C12 cell line and (C)
phase contrast of primary muscular culture. Mt indicates myotubes and arrows show myoblasts (Mb) present in the di¡erentiated cul-
ture. Note the presence of cross-striation in one primary cultured myotube.
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2.7. Immuno£uorescence staining for desmin
After ¢xation, cells were washed and incubated for
30 min in blocking solution (PBS containing 0.5%
BSA and 0.05% saponin (w/v)), followed by incuba-
tion for 30 min with monoclonal anti-desmin anti-
body (1/100, clone DE-U-10, Sigma-Aldrich, Saint
Quentin Fallavier, France) followed by FITC conju-
gate sheep anti-mouse IgG (1/100, Sigma-Aldrich).
Nuclei were stained with DAPI (500 ng/ml) for
20 min and the cells were mounted in Mowiol for
examination.
2.8. Microinjection and L-galactosidase
histochemistry
The solution of DNA (pCMV-nls-LacZ) was in-
jected into one myotube nucleus via glass micropip-
ettes having tip diameters ranging from 0.3 to 0.7 Wm
(Femtotips, Eppendorf, Hamburg, Germany) at
Fig. 2. Fluorescence microscopy of myoblasts from primary culture incubated with £uorescent cationic lipid, £uorescent DNA, £uores-
cent dextran, or FluoroSpheres. The cells were treated as indicated in Section 2. Myoblasts were transfected with labeled cationic lipid
(3 nmol RPR 120535 and 0.1 nmol RPR 121653 per Wg of plasmid) (A), or with labeled DNA (1 Wg DNA with 3 nmol RPR 120535)
(B), and examined after 24 h. Myoblasts were exposed to 100 nm (C) or 200 nm (D) FluoroSpheres for 24 h at 37‡C. (E) Myoblasts
were exposed for 2 h at 37‡C to rhodamine dextran (1 mg/ml in DMEM).
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0.5 Wg/Wl concentration. Injections were carried out
under visual control on a ¢xed stage of an inverted
phase contrast microscope (Axiovert 135, Zeiss) us-
ing a Micromanipulator 5171 and a Microinjector
5242 (Eppendorf). The average volume injected into
each nucleus (0.1^0.2 pl) was determined by injecting
35S-dATPKS into cells and measuring the radioactive
content [22]. This corresponded to average 6000^
12 000 plasmid molecules per nucleus. Following
injection, the cells were incubated for 4 h at 37‡C
in a 5% CO2 incubator to allow for reporter gene
expression. Cells were washed three times with
PBS before ¢xation in 1% formaldehyde and 0.2%
glutaraldehyde for 10 min at room temperature. Fur-
ther permeabilization and three washes were per-
formed in PBS containing 2 mM MgCl2, 1 mM
EGTA and 0.02% Nonidet P-40. Finally, samples
were incubated for 2 h at 37‡C in the chromogenic
substrate X-Gal in permeabilization solution con-
taining 4 mM K3Fe(CN)6, 4 mM K4Fe(CN)6 and
Fig. 3. (A^F) Fluorescence microscopy of myotubes from primary culture transfected with £uorescent cationic lipid, £uorescent DNA
or incubated with 70 kDa rhodamine dextran or FluoroSpheres. (AP^FP) Same ¢eld as A^F, but myotubes were labeled by immunocy-
tochemistry with anti-desmin antibodies and FITC-conjugated secondary antibodies. Myotubes were transfected with labeled cationic
lipid (3 nmol RPR 120535 and 0.1 nmol RPR 121653 per Wg of plasmid) (A,AP), or with labeled DNA (1 Wg DNA with 3 nmol RPR
120535) (B,BP). Myotubes were exposed for 2 h at 37‡C to rhodamine dextran (C,CP) (1 mg/ml in DMEM). Myotubes were exposed
to FluoroSpheres with 100 nm (D,DP and E,EP) or 200 nm diameter (F,FP).
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0.4 mg/ml 5-bromochloro-3-indolyl-L-D-galactopyra-
noside (X-Gal). Cells were mounted in Mowiol for
examination.
3. Results
3.1. Gene transfer e⁄ciency
As a cationic lipid model, we used RPR 120535, a
spermine derivative which was shown to transfect
many cell types in vitro and in vivo [21]. The myo-
genic cells were transfected for 2 h with RPR 120535/
pCMV-Luc complexes (3 nmol lipid/Wg DNA) in the
absence of serum, followed by 24 h of incubation in
the presence of serum. As shown in Table 1, the
luciferase activity was not signi¢cantly di¡erent be-
tween the two myogenic cell lines (C2C12 and
C2C7), but was about 10 000-fold higher in myoblast
than myotube cultures, in both cell lines. We asked
whether this decrease in lipofection e⁄ciency: (1)
was a consequence of the incapacity of myotubes
to transcript and translate an exogenous transgene;
or (2) was due to a di¡erence in the uptake of
lipoplexes between myoblasts and myotubes.
The ¢rst hypothesis was studied by nuclear micro-
injection of nls-L-galactosidase encoding plasmids in
myotubes. As shown in Fig. 1A, myotubes could
express the microinjected transgene. Note that the
nls-L-galactosidase protein was able to di¡use in
Fig. 3 (continued).
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the whole myotube, since only one nucleus was in-
jected per cell. Thus, di¡erentiated myotubes in vitro
can readily express a transgene.
3.2. Uptake of lipoplexes
We quanti¢ed the amount of plasmid DNA and
cationic lipid recovered in transfected cells 24 h after
lipofection. We took advantage of a rhodamine-la-
beled cationic lipid analog to RPR 120535, referred
to as RPR 121653, to assay the amount of cationic
lipid associated with, or taken up by myogenic cells.
As indicated in Table 1, for the C2C12 cell line, there
was no signi¢cant di¡erence between the amount of
cationic lipid taken up by myoblasts and myotubes,
and for the C2C7 cell line, the amount of RPR
121653 internalized was 2-fold higher in myoblasts
than in myotubes. To examine if these results could
be in£uenced by the presence of labeled lipid that
was simply bound to plasma membrane but not en-
docytosed, we performed two series of controls.
First, we quanti¢ed labeled lipid in C2C12 cells har-
vested immediately following contact with the lipo-
plexes. In these conditions, less than 0.04 pmol of
RPR 121653 per Wg of protein were detected associ-
ated with the cells. Second, we compared the amount
of lipid associated with the cells after incubation with
the lipoplexes for 2 h at 37 and 4‡C, where endocy-
tosis is inhibited. We found that the uptake of lipid
was reduced by 60% at 4‡C. This suggests that
around 40% of the lipid associated to the cells is
due to simple binding of the lipoplexes to the plasma
membrane.
We also used rhodamine-labeled plasmid to esti-
mate the amount of internalized DNA. As shown in
Table 1, the amount of DNA internalized was not
signi¢cantly di¡erent between the two myogenic cell
lines (C2C12 and C2C7), but was about 3-fold higher
in myoblasts than in myotube cultures, in both cell
lines.
It is important to note that in all the myotube
cultures, residual proliferating myoblastic cells were
always observed (Fig. 1B,C). Consequently, the glob-
al quanti¢cation of luciferase activity, of cationic lip-
id and of plasmid uptake in di¡erentiated cultures
could not discriminate between subpopulations of
myoblasts and myotubes. In myotubes cultures
transfected with L-galactosidase encoding plasmids,
the expression was exclusively detected in myoblasts
(data not shown).
3.3. E¡ect of myogenic di¡erentiation on lipoplex
intracellular localization
We next investigated whether myogenic di¡erentia-
tion had an e¡ect on the intracellular localization of
the lipoplexes. The intracellular localization of the
lipoplexes was analyzed by £uorescent microscopy,
using either the £uorescent cationic lipid RPR
121653 or a nick-translated plasmid with £uorescent
dUTP-red. Rhodamine-dextran, or rhodamine-la-
beled carboxylate-modi¢ed microspheres with known
diameter (FluoroSpheres) were also used as controls.
Fluorescent microscopy makes it possible to precisely
analyze the internalization of cationic lipid/DNA
complexes in cultures containing both myoblasts
and myotubes.
We found that cationic lipid and plasmid DNA
were present in 100% of mononucleated myoblasts
from primary culture, displaying a punctated cyto-
plasmic staining, mostly in the perinuclear region
(Fig. 2A,B). Similarly, myoblasts were shown to en-
docytose 100- or 200-nm microspheres (Fig. 2C,D)
and £uorescent dextran (Fig. 2E). Similar results
Table 1
Comparison of cationic lipid-mediated gene transfer, cationic lipid uptake (RPR 121653) and DNA uptake by myoblasts and myo-
tubes from C2C12 and C2C7 cell lines
C2C12 C2C7
Myoblasts Myotubes Myoblasts Myotubes
Transfection (RLU/Wg protein) 5.95 þ 2.49U105 (12) 88 þ 76 (12) 9.72 þ 1.80U105 (6) 62 þ 71 (12)
RPR 121653 uptake (pmol/Wg protein) 1.97 þ 0.79 (12)a 1.55 þ 0.05 (12)a 2.38 þ 0.86 (12)c 1.14 þ 0.66 (12)c
Fluorescent DNA uptake (ng/Wg protein) 0.97 þ 0.21 (3)b 0.33 þ 0.21 (3)b 0.75 þ 0.17 (6)c 0.20 þ 0.04 (6)c
Statistical di¡erence between myoblasts and myotubes for each cell line (number of wells) : anot signi¢cant; bP6 0.05; cP6 0.001.
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were obtained with myoblasts of the C2C12 and
C2C7 cell lines (data not shown).
On the contrary, no vesicular staining was ob-
served in myotubes from primary muscular cultures,
whereas a clear uptake of £uorescent lipoplexes was
detected in myoblasts from the same well (Fig.
3A,B). Rhodamine-labeled dextran was endocytosed
by myotubes (Fig. 3C). The size of FluoroSpheres
clearly in£uenced their internalization by myotubes.
Some myotubes were able to take up microspheres
Fig. 4. Fluorescence microscopy of C2C12 myotubes transfected with £uorescent cationic lipid (3 nmol RPR 120535 and 1 nmol RPR
121653 per Wg of plasmid) (A^C). Nuclei were stained with DAPI (AP^CP). The percentage of myotubes was calculated as the number
of nuclei residing within any cell containing more than two nuclei divided by the total nuclear count in a ¢eld of view. Five separate
¢elds were scored for each di¡erentiation state. Note that cationic lipid uptake by myotubes was inversely related with the degree of
fusion.
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with 100 nm diameter (Fig. 3D), whereas other my-
otubes did not (Fig. 3E). Microspheres with 200 nm
diameter were never detected in di¡erentiated cells
(Fig. 3F).
Using the C2C12 cell line, we studied the uptake
of £uorescent lipoplexes as a function of cell fusion,
which is an estimate of myotubes di¡erentiation.
Cultures incubated in di¡erentiation medium for var-
ious periods of time and showing di¡erent levels of
fusion were examined. The percentage of myotubes
in C2C12 cultures was taken as the number of nuclei
residing within any cell containing more than two
nuclei, divided by the total nuclear count in a view
¢eld [23]. We found that the uptake of cationic lipid
by myotubes was inversely related to the degree of
fusion (Fig. 4).
4. Discussion
In the present work, we show that the e⁄ciency of
transfection of pCMV-Luc plasmid complexed with
cationic lipids was dependent upon the di¡erentia-
tion state of the muscle cell cultures in vitro, with
decreasing expression of a reporter gene as myoblasts
fuse into myotubes. These results are in agreement
with earlier reports obtained with di¡erent lipid for-
mulations, in which it was suggested that cell division
might be critical for e⁄cient gene transfer [17,24].
Indeed, mitosis might be requisite for exogenous
DNA to enter the nucleus and to access the nuclear
transcriptional machinery, because during cell prolif-
eration the nuclear envelope is transiently dispersed.
Although this hypothesis might be valid, our present
studies with £uorescent cationic lipid and £uorescent
plasmid suggest that the absence of transgene expres-
sion in myotubes cultures can be explained by a low
e⁄ciency of lipoplex internalization. Quanti¢cation
of the amount of £uorescent plasmid recovered in
transfected cells after lipofection indeed showed
that the uptake of DNA was 3-fold higher in myo-
blasts cultures than in di¡erentiated cultures enriched
in myotubes. The amount of cationic lipid associated
with the cells was not di¡erent between myoblasts
and myotubes of the C2C12 cell line and was 2-
fold higher in myoblasts than in myotubes of the
C2C7 cell line. These results can be explained by
the fact that a signi¢cant part of the £uorescence
associated with the cells was due to lipid bound to
the plasma membrane and not internalized by endo-
cytosis. Moreover, these assays cannot distinguish
between lipoplexes associated with myotubes and
those associated with myoblasts that are always
present in the culture wells.
Consequently, we followed the cellular internaliza-
tion of £uorescent lipoplexes by microscopy. Our
results show an absence of lipoplex endocytosis by
myotubes, whereas myoblasts take up a large
amount of lipoplexes recovered inside cytoplasmic
subcellular compartments. Pictures obtained with
RPR 121653 generally showed a non-speci¢c di¡u-
sion of this £uorescent cationic lipid on the whole
myotube surface (Figs. 3 and 4), again suggesting
that a signi¢cant part of RPR 121653 was bound
to the plasma membrane. Incubation with dextran
showed that there was no di¡erence on £uid phase
endocytosis between myoblasts and myotubes-en-
riched culture (Fig. 3C). On the other side, using
size-calibrating £uorescent latex particles (Fluoro-
Spheres), we determined that myotubes could not
take up particles greater than 200 nm in diameter.
Recently, it was determined that our cationic lipid/
DNA complexes preformed in 150 mM NaCl, form
stable particles in the 500^1000-nm range in DMEM
without serum [20]. This suggests that lipoplexes
formed with RPR 121653 cannot be internalized by
myotubes because of their size. On the contrary,
mononucleated cells, such as ¢broblasts [20] or my-
oblasts (this study), have the capacity to take up
large particles, with a diameter up to 500 nm.
The relevance of these results to the in vivo situa-
tion has to be further analyzed, since non-coated
DNA was not taken up by cultured myotubes, in
contrast to the in vivo gene transfer data.
The di¡erentiation of skeletal myogenic cells is
characterized by: (1) myoblasts fusion; (2) synthesis
of myogenic factors; (3) cell division arrest [25] ; (4)
synthesis of extracellular components that facilitate
adhesion to the tissue support [26]; and (5) forma-
tion of speci¢c cellular structures, such as sarco-
meres, sarcoplasmic reticulum [27], and transverse
tubules [28]. Any of these factors could be responsi-
ble for the di¡erences in particle internalization by
myogenic cells during their cellular di¡erentiation. A
change of the surface charge might also in£uence the
entry of cationic lipid/DNA complexes into myogen-
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ic cells, as observed in di¡erentiated airway epithelial
cells [16].
In conclusion, the di¡erentiation state of myogenic
cells in£uences their capacity to internalize DNA
from plasmid/cationic lipid complexes in vitro. In
myoblasts, high transgene expression and lipoplex
(RPR 121653/DNA complexes) internalization was
observed, as in ¢broblasts [20], whereas, in cultured
di¡erentiated myotubes, no transgene expression was
detected and this absence of expression was corre-
lated with the absence of lipoplex internalization.
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